ACCI及频繁住院对慢阻肺患者30天内再住院的预测价值
Predictive Value of ACCI and Frequent Hospitalisations for Rehospitalisation within 30 Days in Patients with COPD
DOI: 10.12677/acm.2025.1572172, PDF,   
作者: 杜紫轩, 杨丽菁:承德医学院研究生学院,河北 承德;景卫革*:承德市中心医院呼吸与危重症科,河北 承德
关键词: 经年龄调整的查尔森共病指数慢阻肺再住院危险因素Age-Adjusted Charlson Comorbidity Index Chronic Obstructive Pulmonary Disease Rehospitalisation Risk Factors
摘要: 目的:本研究拟探讨ACCI及近1年内频繁住院对慢阻肺患者30天内再住院的影响。为了更有效地识别慢阻肺患者中的高危患者群体,本研究致力于寻找单一的或联合的预测指标。这些指标将帮助我们早期识别并干预那些可控的高危因素,从而优化患者的预后,减少再住院率和病死率,进而减轻社会和家庭的经济与精神负担。方法:选取2020年1月至2023年12月承德市中心医院收治的慢阻肺患者作为观察对象,根据是否30天内再住院分为再住院组和非再住院组,将30天内再住院的患者55例作为再住院组,将30天内未再住院的患者随机抽样51例作为对照组。使用Logistic回归评估患者30天内再住院的危险因素。结果:再住院组年龄、频繁住院高于非再住院患者。BMI、RDW、中性粒细胞计数、中性粒细胞百分比、NLR、NPAR、ALB、PNI、ACCI、ADL评分、PaO2、首次住院天数、使用静脉抗生素天数低于非再住院患者。P值均小于0.05,差异有显著性。Logistic回归分析提示ACCI (OR = 2.293, 95%CI: 1.120~4.694, P < 0.05)、ADL评分(OR = 0.946, 95%CI: 0.898~0.997, P < 0.05)、近1年内频繁住院(OR = 0.065, 95%CI: 0.006~0.769, P < 0.05)是30天内再住院的独立危险因素。结论:ACCI、ADL评分和近1年内频繁住院是慢阻肺患者30天内再住院的独立危险因素。通过干预改善患者并发症及降低患者频繁住院次数,可减少患者再住院风险,对再住院的早期干预有一定的临床价值。
Abstract: Objective: This study intends to investigate the impact of ACCI and frequent hospitalisations within the last 1 year on readmissions within 30 days in patients with chronic obstructive pulmonary disease. In order to more effectively identify high-risk patient groups among patients with chronic obstructive pulmonary disease (COPD), this study is dedicated to finding single or combined predictive indicators. These indicators will help us to identify and intervene early on those controllable high-risk factors, thus optimising patient prognosis, reducing re-hospitalisation and morbidity and mortality, and in turn reducing the economic and emotional burden on society and families. Methods: Patients with chronic obstructive pulmonary disease admitted to Chengde City Central Hospital from January 2020 to December 2023 were selected as observation subjects, and were divided into rehospitalisation and non-rehospitalisation groups according to whether they had been rehospitalised within 30 days; 55 patients who had been rehospitalised within 30 days were treated as the rehospitalisation group, and 51 patients who had not been rehospitalised within 30 days were randomly sampled as the control group. Logistic regression was used to assess the risk factors for readmission of patients within 30 days. Results: Age and frequent hospitalisation were higher in the rehospitalisation group than in the non-rehospitalised patients. BMI, RDW, neutrophil count, neutrophil percentage, NLR, NPAR, ALB, PNI, ACCI, ADL scores, PaO2, number of days to first hospitalisation, number of days on intravenous antibiotics were lower than in the non-rehospitalised patients. The P-value was less than 0.05 and the difference was significant. Logistic regression analysis suggested that ACCI (OR = 2.293, 95% CI: 1.120~4.694, P < 0.05), ADL score (OR = 0.946, 95% CI: 0.898~0.997, P < 0.05), and frequent hospitalisation in the last 1 year (OR = 0.065, 95% CI: 0.006~0.769, P < 0.05) were independent risk factors for rehospitalisation within 30 days. Conclusion: ACCI, ADL score and frequent hospitalisation in the last 1 year were independent risk factors for re-hospitalisation within 30 days in patients with chronic obstructive pulmonary disease. Intervention to improve patients’ complications and reduce the number of frequent hospitalisations can reduce the risk of rehospitalisation and has some clinical value in early intervention for rehospitalisation.
文章引用:杜紫轩, 景卫革, 杨丽菁. ACCI及频繁住院对慢阻肺患者30天内再住院的预测价值[J]. 临床医学进展, 2025, 15(7): 1670-1677. https://doi.org/10.12677/acm.2025.1572172

参考文献

[1] 梁振宇, 王凤燕, 陈子正, 等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2023, 26(11): 1287-1298.
[2] (2020) Global Burden of 369 Diseases and Injuries in 204 Countries And Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204-1222.
[3] (2024) Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD: 2023.
https://goldcopd.org/2023-gold-report/
[4] Gu, Y., Ye, X., Liu, Y., et al. (2021) A Risk-Predictive Model for Invasive Pulmonary Aspergillosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Respiratory Research, 22, Article No. 176. [Google Scholar] [CrossRef
[5] Peng, J., Chen, C., Zhou, M., Xie, X., Zhou, Y. and Luo, C. (2020) A Machine-Learning Approach to Forecast Aggravation Risk in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Clinical Indicators. Scientific Reports, 10, Article No. 3118. [Google Scholar] [CrossRef] [PubMed]
[6] 宋伟伟, 常双喜, 禹彩霞, 等. 慢性阻塞性肺疾病合并肺部感染者Th17/Treg、IL-17水平与肺功能及CAT评分的关系[J]. 中国老年学杂志, 2022, 42(8): 1843-1846.
[7] 尚召明, 王世伟, 熊剑飞, 等. 年龄校准的查尔森共病指数对脓毒症患者预后的评估价值[J]. 临床急诊杂志, 2022, 23(5): 299-304.
[8] Hegewald, M.J., Horne, B.D., Trudo, F., Kreindler, J.L., Chung, Y., Rea, S., et al. (2020) Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2629-2641. [Google Scholar] [CrossRef] [PubMed]
[9] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2023年更新版) [J]. 国际呼吸杂志, 2023, 43(2): 132-1049.
[10] Ruan, H., Zhao, H., Wang, J., Zhang, H. and Li, J. (2023) All-Cause Readmission Rate and Risk Factors of 30-and 90-Day after Discharge in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Therapeutic Advances in Respiratory Disease, 17, 1-16. [Google Scholar] [CrossRef] [PubMed]
[11] Krumholz, H.M., Lin, Z., Keenan, P.S., Chen, J., Ross, J.S., Drye, E.E., et al. (2013) Relationship between Hospital Readmission and Mortality Rates for Patients Hospitalized with Acute Myocardial Infarction, Heart Failure, or Pneumonia. JAMA, 309, 587-593. [Google Scholar] [CrossRef] [PubMed]
[12] 伊永菊, 赖炳佳, 黄蓓丽, 等. 决策支持平台助力三级综合医院评审[J]. 医学信息学杂志, 2017, 38(6): 35-39.
[13] Maria, C.N., Caecilia, B.W., Mark, G.P., et al. (2022) Hospital Readmission Due to Chronic Obstructive Pulmonary Disease: A Longitudinal Study. International Journal of Health Policy and Management, 11, 2533-2541.
[14] Buhr, R.G., Jackson, N.J., Dubinett, S.M., Kominski, G.F., Mangione, C.M. and Ong, M.K. (2020) Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Journal of Hospital Medicine, 15, 219-227. [Google Scholar] [CrossRef] [PubMed]
[15] Venkatesan, P. (2024) GOLD COPD Report: 2024 Update. The Lancet Respiratory Medicine, 12, 15-16. [Google Scholar] [CrossRef] [PubMed]
[16] 石齐芳, 盛鹰, 王树云. 慢性阻塞性肺疾病合并症评分系统的研究进展[J]. 中国全科医学, 2018, 21(4): 497-500.
[17] Fontenele, F.I.G., Tiemi, C.T., Pereira, M.S.D.M.S., et al. (2020) Activities of Daily Living and Life-Space Mobility in Older Adults with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 69-77.
[18] 付睿. 云南省某三甲医院慢阻肺患者31天再入院现状调查及影响因素分析[D]: [硕士学位论文]. 昆明: 昆明医科大学, 2022.
[19] Njoku, C.M., Hurst, J.R., Kinsman, L., Balogun, S. and Obamiro, K. (2023) COPD in Africa: Risk Factors, Hospitalisation, Readmission and Associated Outcomes—A Systematic Review and Meta-Analysis. Thorax, 78, 596-605. [Google Scholar] [CrossRef] [PubMed]
[20] Guerrero, M., Crisafulli, E., Liapikou, A., Huerta, A., Gabarrús, A., Chetta, A., et al. (2016) Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLOS ONE, 11, e0150737. [Google Scholar] [CrossRef] [PubMed]